Serum Arginase, a biomarker of treatment efficacy in human African trypanosomiasis

5Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Arginase serum levels were increased in human African trypanosomiasis patients and returned to control values after treatment. Arginase hydrolyzes L-arginine to L-ornithine, which is essential for parasite growth. Moreover, L-arginine depletion impairs immune functions. Arginase may be considered as a biomarker for treatment efficacy. © 2013, American Society for Microbiology.

Cite

CITATION STYLE

APA

Nzoumbou-Boko, R., Dethoua, M., Gabriel, F., Buguet, A., Cespuglio, R., Courtois, P., … Vincendeau, P. (2013). Serum Arginase, a biomarker of treatment efficacy in human African trypanosomiasis. Journal of Clinical Microbiology, 51(7), 2379–2381. https://doi.org/10.1128/JCM.03371-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free